Efficacy and safety of valganciclovir vs. oral ganciclovir for ... | 合法藥品大搜索

由 吳尚儒 著作 — 免疫低下的族群，如接受器官移植及愛滋病患者，CMV 感染症可能產生嚴重的併發症甚至死. 亡。重症病患是近年 ... 重CMV 肺炎使用ganciclovir 的案例系列報告，. Read More

由 藥劑部 著作 · 2015 — 其中巨細胞病毒視網膜炎（CMV retinitis）是AIDS 病人常見的眼睛感染， ... ganciclovir、 foscarnet、cidofovir 來治療，其中台灣目前只有ganciclovir 可以使用，而. Read More

由 KC Zachary 著作 · 被引用 4 次 — RELATED TOPICS · INTRODUCTION. Ganciclovir was the first antiviral agent approved for the treatment of cytomegalovirus (CMV) infection. Read More

由 TE Nevins 著作 · 1992 · 被引用 64 次 — Ganciclovir (9-(1,3-dihydroxy-2-propoxymethyl) guanine, DHPG) is an acyclovir analog with excellent antiviral activity against human cytomegalovirus (CMV). Read More

由 G Boivin 著作 · 1993 · 被引用 79 次 — Ganciclovir susceptibility studies were done on the last cytomegalovirus (CMV) isolate available from 42 solid organ transplant recipients with CMV viremia who​ ... Read More

由 C Paya 著作 · 2004 · 被引用 865 次 — We compared the efficacy and safety of valganciclovir with those of oral ganciclovir in preventing cytomegalovirus (CMV) disease in high-risk seronegative solid ... Read More

由 CE Fisher 著作 · 2017 · 被引用 58 次 — GanR-CMV is associated with longer prior antiviral duration and higher ... and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in ... Read More

由 RS Cvetković 著作 · 2005 · 被引用 141 次 — Valganciclovir (Valcyte) is an orally administered prodrug of the standard anti-​cytomegalovirus (CMV) drug ganciclovir. Valganciclovir is as effective as ... Read More

由 A Asberg 著作 · 2009 · 被引用 179 次 — Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant. 2009 May ... Read More

由 S Vaziri 著作 · 2014 · 被引用 14 次 — Cytomegalovirus (CMV), a problematic virus in solid organ transplant recipients (​SOTR) such as liver, can worsen overall mortality and transplant outcome, so its ... Read More